Maravai LifeSciences【MRVI】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

2.25

買値

2.10

売値

2.20

出来高

2,473,253

2.08 日の範囲 2.24

1.665 52 週間の範囲 10.03

時価総額

572.984M

前日終値

2.11

始値

2.15

時刻

2.24

最終取引時間

財務取引量

US$ 5,336,396

VWAP

2.1576

平均取引量 (3 か月)

1,966,157

発行済株式数

254,659,517

配当利回り

PER

-3.90

1 株当たり利益 (EPS)

-0.57

歳入

262.4M

純利益

-144.85M

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It ... Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

本社

Wilmington, Delaware, USA

設立

Maravai LifeSciences Holdings Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker MRVI. The last closing price for Maravai LifeSciences was US$2.11. Over the last year, Maravai LifeSciences shares have traded in a share price range of US$ 1.665 to US$ 10.03.

Maravai LifeSciences currently has 254,659,517 shares in issue. The market capitalisation of Maravai LifeSciences is US$537.33 million. Maravai LifeSciences has a price to earnings ratio (PE ratio) of -3.90.

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors

SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global...

TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology

Quantoom’s customers can now access TriLink’s CleanCap mRNA capping technology; Agreement supports future expansion of essential therapeutics...

CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report

Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to...

Maravai LifeSciencesReleases 2024 Sustainability Report

Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to...

TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions

New all-in-one IVT kit can deliver up to 2X more mRNA and up to 85% lower dsRNA compared to other kits on the market through streamlined mRNA...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.13	6.1320754717	2.12	2.25	2	1810790	2.06573408	CS
4	0.02	0.896860986547	2.23	2.44	2	1541868	2.1972694	CS
12	0.03	1.35135135135	2.22	2.44	1.665	1966157	2.06373502	CS
26	-2.9	-56.3106796117	5.15	6.21	1.665	2573513	3.03012822	CS
52	-5.02	-69.0508940853	7.27	10.03	1.665	2311404	5.10625605	CS
156	-25.96	-92.0241049273	28.21	30.44	1.665	2205800	9.56852046	CS
260	-28.86	-92.7675988428	31.11	63.55	1.665	1990438	17.1921923	CS

MRVI - Frequently Asked Questions (FAQ)

What is the current Maravai LifeSciences share price?

The current share price of Maravai LifeSciences is US$ 2.25

How many Maravai LifeSciences shares are in issue?

Maravai LifeSciences has 254,659,517 shares in issue

What is the market cap of Maravai LifeSciences?

The market capitalisation of Maravai LifeSciences is USD 537.33M

What is the 1 year trading range for Maravai LifeSciences share price?

Maravai LifeSciences has traded in the range of US$ 1.665 to US$ 10.03 during the past year

What is the PE ratio of Maravai LifeSciences?

The price to earnings ratio of Maravai LifeSciences is -3.9

What is the cash to sales ratio of Maravai LifeSciences?

The cash to sales ratio of Maravai LifeSciences is 2.15

What is the reporting currency for Maravai LifeSciences?

Maravai LifeSciences reports financial results in USD

What is the latest annual turnover for Maravai LifeSciences?

The latest annual turnover of Maravai LifeSciences is USD 262.4M

What is the latest annual profit for Maravai LifeSciences?

The latest annual profit of Maravai LifeSciences is USD -144.85M

What is the registered address of Maravai LifeSciences?

The registered address for Maravai LifeSciences is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

Which industry sector does Maravai LifeSciences operate in?

Maravai LifeSciences operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
NKTRNektar Therapeutics	US$ 24.435 (156.13%)	37.17M
ONMDOneMedNet Corporation	US$ 0.6801 (100.03%)	495.97M
YAASYouxin Technology Ltd	US$ 5.58 (95.45%)	22.94M
EYENEyenovia Inc	US$ 9.005 (64.32%)	41.87M
SOGPSound Group Inc	US$ 4.20 (59.70%)	1.81M
UPXIUpexi Inc	US$ 3.9693 (-60.31%)	5.84M
FTRKFast Track Group	US$ 3.22 (-48.97%)	9.45M
MAASMaase Inc	US$ 6.27 (-36.86%)	1.68M
GIBOGIBO Holdings Ltd	US$ 0.3681 (-34.96%)	28.93M
XTKGX3 Holdings Company Ltd	US$ 1.435 (-34.77%)	430.4k
ONMDOneMedNet Corporation	US$ 0.6801 (100.03%)	495.97M
HCTIHealthcare Triangle Inc	US$ 0.034 (9.68%)	389M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 13.625 (-5.32%)	222.71M
GNLNGreenlane Holdings Inc	US$ 0.009 (1.12%)	195.14M
NVDANVIDIA Corporation	US$ 147.90 (2.59%)	187.6M